期刊文献+

重组慢病毒载体pLKO-1-EGFP-puro的构建 被引量:2

Construction of a noval lentiviral vector pLKO-1-EGFP-puro
下载PDF
导出
摘要 目的:构建具有绿色荧光蛋白(GFP)标记及嘌呤霉素(puro)抗性的重组慢病毒载体。方法:改建慢病毒载体质粒pLKO-1-puro的多克隆位点(MCS),以质粒pEGFP-C3为模板扩增出CMV-EGFP并与pLKO-1-puro连接,形成重组的慢病毒载体质粒pLKO-1-EGFP-puro,后者与包装质粒Δ8.2和包膜蛋白质粒VSV-G在293T细胞中进行包装,产生重组慢病毒颗粒,感染非洲绿猴肾细胞Vero细胞,观察GFP的表达。结果:成功改建了慢病毒载体质粒pLKO-1-puro并插入了CMV-EGFP,形成了新型慢病毒载体质粒pLKO-1-EGFP-puro。3质粒共转染293T细胞产生的重组慢病毒颗粒感染Vero细胞后高表达绿色荧光。结论:成功构建了高效的带GFP报告基因及嘌呤霉素抗性的慢病毒载体。 Aim:To construct lentiviral vector with green fluorescent protein(GFP) and puromycin(puro)-resistant gene.Methods:The multiple clone site(MCS) of lentiviral plasmid pLKO-1-puro was reconstructed to be more compatible,and CMV-EGFP was also amplified from plasmid pEGFP-C3 by PCR. After double digestion, the new pLKO-1-puro and CMV-EGFP sequences were ligated to form another lentiviral plasmid pLKO-1-EGFP-puro,which was cotransfected into 293T cells with packaging plasmid Δ8.2 and envelop plasmid VSV-G to produce recombined lentivirus particles. Finally, the GFP expression was assayed by lentivirus infected Vero cells.Results:The MCS of pLKO-1-puro was successfully reconstructed.The new pLKO-1-puro was also inserted correctly by CMV-EGFP to form recombined pLKO-1-EGFP-puro. Lentiviral particles produced by cotransfection of three plasmids into 293T cells had high GFP expression in Vero cells.Conclusion: Recombinant lentiviral vector with GFP gene and puro resistance has been successfully constructed.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第6期926-928,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省教育厅自然科学基础研究计划基金资助项目2007310016
关键词 神经系统遗传病 慢病毒载体 绿色荧光蛋白 嘌呤霉素抗性 neurological genetic disease lentiviral vector green fluorescent protein puromycin resistance
  • 相关文献

参考文献6

  • 1Wong LF, Goodhead L, Prat C, et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications [ J ]. Hum Gene Ther,2006,17 ( 1 ) : 1.
  • 2Jakobsson J, Lundberg C. Lentiviral vectors for use in the central nervous system [ J ]. Mol Ther,2006,13 ( 3 ) :484.
  • 3Xu K, Ma H, McCown TJ, et al. Generation of a stable cell lineproducing high-titer self-inactivating lentiviral vectors[J]. Mol Ther,2001,3(1):97.
  • 4Azzouz M, Kingsman SM, Mazarakis ND. Lentiviral vectors for treating and modeling human CNS disorders[ J ]. J Gene Med, 2004,6(9) :951.
  • 5Vercammen L, Van der Perren A, Vaudano E, et al. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson' s disease[ J ]. Mol Ther, 2006,14 (5) :716.
  • 6Ben-Dor f, hsykson P, Goldenberg D, et al. Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells[J]. Mol Ther, 2006. 14(2), 255.

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部